Skip to content

GH secretagogue · compound · regulatory review 2026-10-09

CJC-1295 (With DAC)

Growth-hormone-releasing-hormone analogue; DAC and non-DAC naming must not be treated as interchangeable.

The cited evidence and any approval concern the studied or labeled preparation. Oral, nasal, cosmetic and research-market versions do not inherit product approval or proven efficacy.

Editorial review 2026-10-09. source-curated; clinician review pending.

FDA product
not established
Compounding
not established
Research
investigational
Sport
prohibited

What is CJC-1295 (With DAC)?

DAC and no-DAC versions are different molecules. A Drug Affinity Complex changes how long it lasts. Seller titles that say “CJC-1295 no DAC (Mod GRF 1-29)” should be read as that sequence. They are not proven DAC-CJC-1295. The parent card and the no-DAC card stay linked so the names do not collapse.

In plain language

CJC-1295 is a lab-made stand-in for GHRH, the signal that can raise growth hormone. Research-market listings next to this name are mostly “no DAC” / Mod GRF 1-29 vials at 5 mg, 8 mg, and 10 mg. This source set has no FDA-approved CJC-1295 drug. Names stay split.

What the evidence says

For each trial, check who or what was studied, which preparation was used and what the findings support before comparing it with personal reports about individual experiences or seller listings that describe a product but don’t establish that it works.

Human trial

Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults.

Healthy adults aged 21-61, 28/49-day experiments

Reported findings. Increased GH and IGF-I

Nonresponse. No recovery/body-composition outcome established

Harms. No serious reactions reported during short study; not long-term safety

Limits. No transfer to other routes/formulations/indications; clinician review pending.

Preparation: Long-acting CJC-1295 with DAC, not no-DAC Route: subcutaneous

Read original source ↗

Editorial review 2026-10-09. Clinician review pending.

Regulatory status, dated 2026-10-09

FDA product approval

not established. No US therapeutic product approval is established by this curated source set; other countries and products may differ.

Compounding

not established. Compounded products do not carry FDA product approval; legal eligibility is not established here.

Research

investigational. Limited human pharmacology data; no general wellness outcome established here.

Sport

prohibited. WADA S2 lists this GHRH analogue.

How long it lasts, how you store it, listed sizes

This entry doesn’t give a duration in hours. No verified formulation-specific human estimate in this source set; no guessed value is supplied.

The units charts use 5 mg, 8 mg, and 10 mg because those amounts appear on CJC-1295 no-DAC seller listings.

U-100 math for listed CJC-1295 (With DAC) sizes. Each cell is micrograms per syringe mark if you add that much liquid. The table does the same math as the calculator. It does not pick an amount for you.

These vial sizes come from seller listings for related CJC-1295 no-DAC products.

Micrograms per U-100 unit (100 marks / mL)
Listed vial1 mL liquid2 mL liquid3 mL liquid
5 mg502516.7
8 mg804026.7
10 mg1005033.3

Risks and mix-ups already on the record

  • FDA reports cardiovascular adverse events.
  • Unknown or incomplete for research formulations; this is not a clearance for use.
  • Unknown or incomplete; do not infer compatibility with medications or other substances.

People using PepBear often log: Existing clinician-directed records, symptoms and dated health measurements. Record missing data; trends do not demonstrate causation.

Sources

  1. Primary evidence or regulator source · checked 2026-10-09
  2. WADA prohibited list · checked 2026-10-09
  3. CJC-1295 PK (PubMed 16352683) · checked 2026-10-09
  4. CJC-1295 IGF-1 (PubMed 17018654) · checked 2026-10-09

Questions people ask

Is CJC-1295 the same as sermorelin?

Both touch the GHRH path in different ways. Sermorelin had a former approved product (Geref) that was later pulled. CJC-1295 did not.

Why does the chart mention no-DAC sizes?

The vendor records don’t list a milligram size for the parent CJC-1295 entry. The chart uses sizes from the related no-DAC listings and labels that distinction.

Related cards

A licensed clinician must interpret the evidence for your situation. This entry provides education, not treatment instructions. Not medical advice. PepBear does not pick a dose, a cycle, or a seller.

Optional merchant comparison

Where to buy CJC-1295 (With DAC)

Compare the same identity, formulation and format. Blends, oral products and different variants stay separate. A lower price does not establish product quality or medical suitability.

We earn a commission when you buy through PepStar LLC partner links or codes RICHPEP and PEPBEAR. Merchant listings are separate from the evidence and do not establish product quality or medical suitability.

No exact product listing is verified for this identity yet.